1 / 4

Conference on Radiopharmaceuticals in Russia: Industry Overview and Solutions

This corporate communication center event focuses on radiopharmaceuticals, discussing challenges and resolutions in the sector. It covers topics like radionuclide therapy, production, and market capacity. The conference aims to promote the development of laws and regulations in radiopharmacy. Strategic partnerships and joint ventures for radiopharmaceutical production are highlighted. Attendees explore the evolving landscape of therapeutic radiopharmaceuticals in Russia.

brownchad
Download Presentation

Conference on Radiopharmaceuticals in Russia: Industry Overview and Solutions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MINPROMTORG OF RUSSIA SID & GP IV ALL-RUSSIA GMP CONFERENCE Therapeutic radiopharmaceuticals in Russia: state of the industry, main problems and ways to overcome them Corporate Communication Center A.V.ZVEREV

  2. Зверев А.В. RADIONUCLIDE THERAPY IN FIGURES “Strontium chloride, Sr-89” “Samarium oxabifor, Sm-153” beds in use “Xofigo” in project “Sodium iodide,I-131” General partner: Strategic partners: Official partners: Regional partners:

  3. - “Do I need a registration?” 4 radiopharmaceuticals 12 departments of radionuclide therapy "Production", "Manufacturing", "Preparation" ... HOW? LOW MARKET CAPACITY NO -guidelines for the assignment of RNT -targeted therapeutic radiopharmaceuticals General partner: Strategic partners: Official partners: Regional partners:

  4. DEVELOPMENT OF LAWS AND REGULATIONS IN THE FIELD OF RADIOPHARMACY The opening of the planned departments of radionuclide therapy will allow: Creation of a joint venture for the production of radiopharmaceuticals hold up prices for radiopharmaceuticals for several years lessen the burdenof existing centers FMBA of Russia SC Rosatom train more nuclear medicine doctors General partner: Strategic partners: Official partners: Regional partners:

More Related